Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2018 2
2019 3
2021 5
2022 4
2023 8
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Bioequivalence studies with anti-TNF biosimilars.
Gimeno-Gracia M, Gargallo-Puyuelo CJ, Gomollón F. Gimeno-Gracia M, et al. Among authors: gargallo puyuelo cj. Expert Opin Biol Ther. 2019 Oct;19(10):1031-1043. doi: 10.1080/14712598.2019.1561851. Epub 2018 Dec 31. Expert Opin Biol Ther. 2019. PMID: 30574813 Review.
Colonic diverticular disease. Treatment and prevention.
Gargallo Puyuelo CJ, Sopeña F, Lanas Arbeloa A. Gargallo Puyuelo CJ, et al. Gastroenterol Hepatol. 2015 Dec;38(10):590-9. doi: 10.1016/j.gastrohep.2015.03.010. Epub 2015 May 12. Gastroenterol Hepatol. 2015. PMID: 25979437 Review.
Adding genetic scores to risk models in colorectal cancer.
Gargallo-Puyuelo CJ, Lanas Á, Asunción García-Gonzalez M. Gargallo-Puyuelo CJ, et al. Oncotarget. 2019 Aug 6;10(47):4803-4804. doi: 10.18632/oncotarget.27110. eCollection 2019 Aug 6. Oncotarget. 2019. PMID: 31448048 Free PMC article. No abstract available.
Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review.
Martínez-Domínguez SJ, García-Mateo S, Laredo V, Gargallo-Puyuelo CJ, Gallego Llera B, López de la Cruz J, Gomollón F. Martínez-Domínguez SJ, et al. Among authors: gargallo puyuelo cj. Cancers (Basel). 2023 Jun 27;15(13):3367. doi: 10.3390/cancers15133367. Cancers (Basel). 2023. PMID: 37444477 Free PMC article. Review.
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
García MJ, Riestra S, Amiot A, Julsgaard M, García de la Filia I, Calafat M, Aguas M, de la Peña L, Roig C, Caballol B, Casanova MJ, Farkas K, Boysen T, Bujanda L, Cuarán C, Dobru D, Fousekis F, Gargallo-Puyuelo CJ, Savarino E, Calvet X, Huguet JM, Kupcinskas L, López-Cardona J, Raine T, van Oostrom J, Gisbert JP, Chaparro M. García MJ, et al. Aliment Pharmacol Ther. 2024 May;59(10):1248-1259. doi: 10.1111/apt.17938. Epub 2024 Mar 6. Aliment Pharmacol Ther. 2024. PMID: 38445785
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study.
Casanova MJ, Nantes Ó, Varela P, Vela-González M, Rivero M, Sierra-Gabarda O, Riestra S, Barreiro-de Acosta M, Martín-Rodríguez MDM, Gargallo-Puyuelo CJ, Reygosa C, Muñoz R, de la Filia-Molina IG, Núñez-Ortiz A, Kolle L, Calafat M, Huguet JM, Iglesias-Flores E, Martínez-Pérez TJ, Bosch O, Duque-Alcorta JM, Frago-Larramona S, Van Domselaar M, González-Cosano VM, Bujanda L, Rubio S, Mancebo A, Castro B, García-López S, de Francisco R, Nieto-García L, Laredo V, Gutiérrez-Casbas A, Mesonero F, Leo-Carnerero E, Cañete F, Ruiz L, Gros B, Del Moral-Martínez M, Rodríguez C, Chaparro M, Gisbert JP. Casanova MJ, et al. Aliment Pharmacol Ther. 2023 Jul;58(1):60-70. doi: 10.1111/apt.17525. Epub 2023 Apr 23. Aliment Pharmacol Ther. 2023. PMID: 37089065
26 results